Literature DB >> 22892960

Diagnosis delay in West syndrome: misdiagnosis and consequences.

Stéphane Auvin1, Adam L Hartman, Béatrice Desnous, Anne-Christine Moreau, Corinne Alberti, Catherine Delanoe, Alfonso Romano, Gaetano Terrone, Eric H Kossoff, Ennio Del Giudice, Luigi Titomanlio.   

Abstract

West syndrome or infantile spasms is one of the most frequent epileptic syndromes in the first year of life. The clinical symptoms of infantile spasms are very different than any other type of seizure because of both the absence of paroxysmal motor phenomena (i.e., as in a convulsion) and the lack of significant duration of loss of consciousness (i.e., as in absence epilepsy). Infantile spasms may lead to misdiagnosis by pediatricians and other primary care providers. We assessed the missed diagnoses prior to the diagnosis of infantile spasms. We hypothesized that a delay in treatment may have consequences on neurologic outcome. We conducted a multicenter, retrospective, observational study to evaluate occurrence of misdiagnosis and its possible consequences. We performed a multivariate analysis to evaluate the risk for the outcome 2 years after the diagnosis of infantile spasms. We included 83 infants over a 5-year period. The majority of consulted physicians (301 of 362) did not suggest any specific diagnosis while the others suggested gastroesophageal reflux (7 %), constipation (7 %), or colitis (3 %). Results indicated that a poor outcome was related to a delay in diagnosis, which was observed regardless of the existence of cognitive involvement prior to the start of infantile spasms (Relative Risk: RR 12.08 [1.52-96.3]). These results highlight the importance of making an early diagnosis of infantile spasms.

Entities:  

Mesh:

Year:  2012        PMID: 22892960     DOI: 10.1007/s00431-012-1813-6

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  19 in total

1.  The risk of lower mental outcome in infantile spasms increases after three weeks of hypsarrhythmia duration.

Authors:  Zvonka Rener Primec; Janez Stare; David Neubauer
Journal:  Epilepsia       Date:  2006-12       Impact factor: 5.864

2.  The effect of lead time to treatment and of age of onset on developmental outcome at 4 years in infantile spasms: evidence from the United Kingdom Infantile Spasms Study.

Authors:  Finbar J K O'Callaghan; Andrew L Lux; Katrina Darke; Stuart W Edwards; Eleanor Hancock; Anthony L Johnson; Colin R Kennedy; Richard W Newton; Christopher M Verity; John P Osborne
Journal:  Epilepsia       Date:  2011-06-10       Impact factor: 5.864

3.  Treatment and long term outcome in West syndrome: the clinical reality. A multicentre follow up study.

Authors:  Lieven Lagae; Helène Verhelst; Berten Ceulemans; Linda De Meirleir; Marie-Cécile Nassogne; Valerie De Borchgrave; Marc D'Hooghe; Martine Foulon; Patrick Van Bogaert
Journal:  Seizure       Date:  2010-02-10       Impact factor: 3.184

4.  Factors associated with treatment lag in infantile spasms.

Authors:  Silvia Napuri; Edouard LE Gall; Olivier Dulac; Jacques Chaperon; Francoise Riou
Journal:  Dev Med Child Neurol       Date:  2010-10-21       Impact factor: 5.449

Review 5.  West syndrome: etiological and prognostic aspects.

Authors:  K Watanabe
Journal:  Brain Dev       Date:  1998-01       Impact factor: 1.961

6.  The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial.

Authors:  Andrew L Lux; Stuart W Edwards; Eleanor Hancock; Anthony L Johnson; Colin R Kennedy; Richard W Newton; Finbar J K O'Callaghan; Christopher M Verity; John P Osborne
Journal:  Lancet Neurol       Date:  2005-11       Impact factor: 44.182

7.  Infantile spasms: outcome and prognostic factors of cryptogenic and symptomatic groups.

Authors:  B Koo; P A Hwang; W J Logan
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

8.  Infantile spasms in Down syndrome--effects of delayed anticonvulsive treatment.

Authors:  Monika Maria Eisermann; A DeLaRaillère; G Dellatolas; E Tozzi; R Nabbout; O Dulac; C Chiron
Journal:  Epilepsy Res       Date:  2003 Jun-Jul       Impact factor: 3.045

Review 9.  Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society.

Authors:  M T Mackay; S K Weiss; T Adams-Webber; S Ashwal; D Stephens; K Ballaban-Gill; T Z Baram; M Duchowny; D Hirtz; J M Pellock; W D Shields; S Shinnar; E Wyllie; O C Snead
Journal:  Neurology       Date:  2004-05-25       Impact factor: 9.910

10.  Long-term otucome of West syndrome: a study of adults with a history of infantile spasms.

Authors:  R Riikonen
Journal:  Epilepsia       Date:  1996-04       Impact factor: 5.864

View more
  13 in total

Review 1.  West Syndrome: A Review and Guide for Paediatricians.

Authors:  Renato D'Alonzo; Donato Rigante; Elisabetta Mencaroni; Susanna Esposito
Journal:  Clin Drug Investig       Date:  2018-02       Impact factor: 2.859

2.  Immediate outcomes in early life epilepsy: A contemporary account.

Authors:  Anne T Berg; Courtney Wusthoff; Renée A Shellhaas; Tobias Loddenkemper; Zachary M Grinspan; Russell P Saneto; Kelly G Knupp; Anup Patel; Joseph E Sullivan; Eric H Kossoff; Catherine J Chu; Shavonne Massey; Ignacio Valencia; Cynthia Keator; Elaine C Wirrell; Jason Coryell; John J Millichap; William D Gaillard
Journal:  Epilepsy Behav       Date:  2019-06-07       Impact factor: 2.937

3.  Diagnostic delays in children with early onset epilepsy: impact, reasons, and opportunities to improve care.

Authors:  Anne T Berg; Tobias Loddenkemper; Christine B Baca
Journal:  Epilepsia       Date:  2013-12-06       Impact factor: 5.864

Review 4.  Latest American and European updates on infantile spasms.

Authors:  Andrew L Lux
Journal:  Curr Neurol Neurosci Rep       Date:  2013-03       Impact factor: 5.081

Review 5.  Neonatal and Infantile Epilepsy: Acquired and Genetic Models.

Authors:  Aristea S Galanopoulou; Solomon L Moshé
Journal:  Cold Spring Harb Perspect Med       Date:  2015-12-04       Impact factor: 6.915

6.  Preclinical Screening for Treatments for Infantile Spasms in the Multiple Hit Rat Model of Infantile Spasms: An Update.

Authors:  Aristea S Galanopoulou; Wenzhu B Mowrey; Wei Liu; Qianyun Li; Oleksii Shandra; Solomon L Moshé
Journal:  Neurochem Res       Date:  2017-05-02       Impact factor: 3.996

Review 7.  Impact of predictive, preventive and precision medicine strategies in epilepsy.

Authors:  Rima Nabbout; Mathieu Kuchenbuch
Journal:  Nat Rev Neurol       Date:  2020-10-19       Impact factor: 42.937

8.  Infantile Spasms: Clinical profile and treatment outcomes.

Authors:  Shazia Kulsoom; Shahnaz H Ibrahim; Sidra Kaleem Jafri; Khemchand N Moorani; Misbah Anjum
Journal:  Pak J Med Sci       Date:  2018 Nov-Dec       Impact factor: 1.088

9.  Radiprodil, a NR2B negative allosteric modulator, from bench to bedside in infantile spasm syndrome.

Authors:  Stéphane Auvin; Blandine Dozières-Puyravel; Andreja Avbersek; David Sciberras; Jo Collier; Karine Leclercq; Pavel Mares; Rafal M Kaminski; Pierandrea Muglia
Journal:  Ann Clin Transl Neurol       Date:  2020-02-27       Impact factor: 4.511

10.  Antiepileptogenic effects of rapamycin in a model of infantile spasms due to structural lesions.

Authors:  Ozlem Akman; Stephen W Briggs; Wenzhu B Mowrey; Solomon L Moshé; Aristea S Galanopoulou
Journal:  Epilepsia       Date:  2021-07-02       Impact factor: 6.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.